Last update09:22:08 AM GMT

Medico Legal

Cost of private practice claims rockets

Compensation claims for multi million pound sums against GPs and consultants in private practice have risen three-fold over the last decade, according to figures released in March by the Medical Defence Union (MDU).

In 2015, the MDU settled 12 compensation claims for more than £1m on behalf of its GP and consultant members. By contrast, in 2005 just four settled claims exceeded the £1m mark and in 1995 only one patient received over £1m in compensation from the MDU.

Over the past three years alone more than £100m has been paid out by the MDU to compensate patients and pay legal costs in 36 medical negligence claims that exceeded £1m. The highest amount paid out by the MDU was £9.2m to compensate a patient rendered tetraplegic after spinal surgery and to pay legal costs. In another case, involving a GP, £8.5m in compensation and legal costs was paid for a missed diagnosis of a subarachnoid haemorrhage.

Last Updated on Thursday, 02 June 2016 09:36


What is a pain medicine specialist?

Your Expert WitnessDr Stephen Humble MBChB MSc PhD FCARCSI, a consultant in anaesthesia and pain medicine at Medicolegal Associates Ltd outlines below exactly what a pain medicine specialist is and role they take as expert witnesses.

A pain medicine specialist is a doctor with specialised training and expertise in all aspects of the diagnosis and management of painful conditions. The field encompasses a wide spectrum, including acute, chronic and cancer pain. In the UK, pain medicine is a subspecialism under the auspices of the Royal College of Anaesthetists. The vast majority of British pain specialists are therefore consultant anaesthetists who have undergone a significant additional period of specialised training. This typically takes the form of an accredited full-time pain fellowship within a recognised pain management centre as part of a (RCoA) pain training programme.

Last Updated on Monday, 25 April 2016 10:21


When ‘never’ in the NHS really means 1,000 times

Your Expert WitnessAnalysis by the Press Association of data on so-called ‘Never Events’ in the NHS was widely reported in February. Never Events are described by the NHS as ‘serious incidents that are wholly preventable, as guidance or safety recommendations that provide strong systemic protective barriers are available at a national level and should have been implemented by all healthcare providers’.

According to the data, nearly 1,200 such events were reported in the period from April 2012 to the end of December last year – 290 in 2012-13, 338 in 2013/14, 306 in 2014/15 and 254 from April to the end of December 2015.

The NHS says: “Each Never Event type has the potential to cause serious patient harm or death. However, serious harm or death is not required to have happened as a result of a specific incident occurrence for that incident to be categorised as a Never Event.”

Last Updated on Monday, 25 April 2016 10:10


Latest report into perinatal maternal deaths welcomed by professions

Your Expert Witness MBRACE-UK reportOn 8 December the MBRRACE-UK team at the National Perinatal Epidemiology Unit published its latest report, Saving Lives, Improving Mothers’ Care. Based at the University of Oxford, MBRRACE-UK (Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across the UK) presented the findings of its maternal mortality surveillance from 2011-2013 in the UK.

The report also carried the lessons learned from the confidential enquiries into maternal deaths of women with mental health-related problems, substance misuse, cancer and blood clots and women who died by homicide.

Last Updated on Thursday, 11 February 2016 16:26


South American implants manufacturer has CE Mark suspended

On 25 September the Medicines & Healthcare products Regulatory Agency (MHRA) announced it had temporarily suspended the use of South American manufacturer Silimed's silicone implants in the UK after its CE Mark had been suspended following an inspection by a German notified body.

In a statement the MHRA said: "The German medical device regulatory authority informed MHRA on Friday 18 September 2015 that a German notified body had temporarily suspended the marketing and distribution of all medical devices manufactured by Silimed.

"A recent inspection of the manufacturing facility by the notified body identified particles on the surface of some devices.

Last Updated on Wednesday, 07 October 2015 13:56